Addus HomeCare (NASDAQ:ADUS) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Addus HomeCare (NASDAQ:ADUS) posted its earnings results on Monday. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02, Briefing.com reports. The company had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.03 earnings per share.

Addus HomeCare Stock Performance

ADUS traded down $7.50 on Tuesday, reaching $121.46. 71,083 shares of the company’s stock were exchanged, compared to its average volume of 130,842. The company’s 50 day moving average is $129.93 and its 200-day moving average is $120.66. The company has a market cap of $2.20 billion, a price-to-earnings ratio of 28.13, a PEG ratio of 2.29 and a beta of 1.04. Addus HomeCare has a twelve month low of $81.51 and a twelve month high of $136.12.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now owns 3,366 shares in the company, valued at approximately $429,165. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 over the last quarter. Company insiders own 4.60% of the company’s stock.

Analyst Ratings Changes

ADUS has been the topic of a number of research reports. Oppenheimer increased their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Macquarie reissued an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday. TD Cowen upped their target price on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. KeyCorp started coverage on Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a research note on Tuesday, September 3rd. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $131.38.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.